control group:Placebo 120mg orally intake twice a day

2 trials

Sponsors

Macau University of Science and Technology

Conditions

PRIMARY MEMBRANOUS NEPHROPATHY

Phase 4

Clinical and basic research of therapy with sinomenine for pimary membranous nephropathy

Active, not recruitingChiCTR2100047996

Macau University of Science and TechnologyPRIMARY MEMBRANOUS NEPHROPATHY

Start: 2021-07-01Updated: 2022-03-07

Clinical and basic research of therapy with sinomenine for pimary membranous nephropathy

Active, not recruitingITMCTR2100004997

Macau University of Science and TechnologyPRIMARY MEMBRANOUS NEPHROPATHY

Start: 2021-07-01Updated: 2023-02-20